Quantum BioPharma - Multiplikator EV/Sales QNTM

Simbol resmi perusahaan Quantum BioPharma (QNTM)

Risks for Quantum BioPharma Ltd (QNTM) are linked to resource allocation across various projects and funding requirements. The EV/Sales trend allows for an assessment of the business's market value relative to sales, where the metric value stands at 0.00. The readiness of plants to scale production and the uniqueness of R&D developments create potential for capturing monopoly positions within medical niches.

QNTM: Nilai perusahaan marang pendapatan Quantum BioPharma Ltd. 23.11.2025 - 20.11.2026

QNTM (Quantum BioPharma Corp): rincian analitis lan laporan miturut indikator

- kuotasi saiki lan rata-rata prakiraan nilai:
Pambiji fundamental:Quantum BioPharma Ltd QNTM
Produk seri Quantum BioPharma Limited

This indicator measures the total enterprise value, including net debt, relative to annual sales to determine the market overvaluation of assets. The current enterprise value-to-sales multiple of 0.00 reflects speculative expectations regarding the R&D pipeline of Quantum BioPharma Ltd. (QNTM), where a high valuation coupled with low commercial revenue makes the company extremely sensitive to clinical trial results.

Analisis pesaing Quantum BioPharma Ltd

HLN: Rasio nilai perusahaan marang pendapatan|Kenvue Corp (KVUE) - Rasio nilai perusahaan marang pendapatan|Verona Pharma PLC - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Jyong Biotech Ltd|Multiplikator EV/Sales Ligand Corp|Multiplikator EV/Sales AMRX|Rasio total nilai perusahaan marang pendapatan Perrigo Company plc|Multiplikator EV/Sales ALVO (Alvotech Biopharmaceuticals)|LQDA: Rasio nilai perusahaan marang pendapatan|Galapagos N.V. - Multiplikator EV/Sales|ANIP - Multiplikator EV/Sales|MNKD: Multiplikator EV/Sales|amphastar.com (AMPH) - Multiplikator EV/Sales|PCRX (Pacira Pharmaceuticals) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan ARS Pharmaceuticals, Inc. (SPRY)|Multiplikator EV/Sales TBPH|AQST (Aquestive Therapeutics) - Nilai bisnis marang pendapatan|scPharmaceuticals, Inc. - Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan TECX|tonixpharma.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan BioHarvest|Nilai perusahaan marang pendapatan EXOZ|Nilai perusahaan marang pendapatan Oramed Pharmaceuticals (ORMP)|Nilai perusahaan marang pendapatan ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales ABVC (ABVC BioPharma Inc)|CPIX - Nilai perusahaan marang pendapatan|FGEN - Rasio nilai perusahaan marang pendapatan|TELO - Multiplikator EV/Sales|Rani Therapeutics Inc (RANI) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan SNYR|Rasio nilai perusahaan marang pendapatan Rallybio Corp|Rasio nilai perusahaan marang pendapatan LEXX|Multiplikator EV/Sales PULM|PTHL: Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales APM (Aptorum Group Ltd)|LYRA - Nilai perusahaan marang pendapatan|Impact BioMedical Inc - Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan TNFA|YCBD (cbdmd.com) - Nilai perusahaan marang pendapatan|painreform.com - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan CYTO|Rasio nilai perusahaan marang pendapatan LIPO|Rasio nilai perusahaan marang pendapatan optinose.com (OPTN)|PIRS (Pieris Pharma) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Procaps Group S.A. PROC|Rasio total nilai perusahaan marang pendapatan petrospharma.com (PTPI)|QLI - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan SLRN (ACELYRIN)|TFF Pharmaceuticals, Inc (TFFP) - Rasio nilai perusahaan marang pendapatan